Freeline announces supply agreement for haemophilia B program

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Announces Pricing of Initial Public Offering
Freeline to Participate in Upcoming Investor Conferences in September 2021
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate for Gaucher Disease, in Late-Breaking Oral Presentation at ASGCT 27th Annual Meeting
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Freeline Announces Updated Development Plan and Timelines for FLT190 for People with Fabry Disease
Freeline Reports January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels